Doctors Note Logo

Published on: 10/1/2026

Can you get the shingles vaccine before 50, and when that is allowed

Yes, in certain cases: Shingrix is approved and recommended for adults 19 and older who are or will be immunodeficient or immunosuppressed due to disease or therapy, such as cancer treatment, organ transplant, HIV, or long-term steroid and immune-suppressing medications. Healthy adults under 50 are generally not eligible under routine guidelines, and insurance coverage often follows those same age and risk rules, so cost and access can vary. Timing also matters, since the two-dose series may be spaced one to two months apart depending on your immune status, and some providers prefer to vaccinate before starting immunosuppressive therapy. There are several other factors to consider, including prior shingles episodes, pregnancy, and current illness. See below to understand the full details before deciding what applies to you.

If you are weighing early vaccination, it usually starts with understanding your own risk profile and whether symptoms like nerve pain, tingling, or a one-sided rash need attention right now. A fast, free, online symptom check can help you clarify what you are experiencing, flag whether urgent care is warranted, and give you clear questions to bring to a clinician so you do not lose time guessing.

Last reviewed for medical accuracy: 10/01/2026

answer background

Explanation

Can You Get the Shingles Vaccine Before 50?

Shingles (herpes zoster) is caused by the reactivation of the chickenpox virus (varicella-zoster). It can lead to a painful rash and complications such as postherpetic neuralgia (long-lasting nerve pain). Vaccination is the best way to reduce your risk. You may be wondering: Can you get the shingles vaccine before 50? Here’s what you need to know, based on credible sources like the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA).


Why Age 50 Is the Standard Guideline

  • ACIP Recommendation
    The Advisory Committee on Immunization Practices (ACIP) recommends the shingles vaccine (Shingrix) for healthy adults aged 50 and older. This age cutoff reflects the balance of risk versus benefit in the general population.
  • Increasing Risk with Age
    After age 50, the risk of developing shingles and its complications rises sharply. Vaccinating at or before this age helps prime the immune system when it’s still relatively robust.

FDA Approval and Use in Younger Adults

Shingrix Approval

  • The FDA initially approved Shingrix for adults 50 and older.
  • In 2021, the FDA expanded approval to include adults aged 18–49 who are at increased risk for shingles due to weakened immunity. This includes people undergoing treatments like chemotherapy, organ transplant recipients, or those with HIV/AIDS.

What “Increased Risk” Means

Adults aged 18–49 may qualify for Shingrix if they have:

  • A weakened immune system from disease (e.g., HIV, lymphoma)
  • A weakened immune system from treatment (e.g., chemotherapy, steroids)
  • Other medical conditions that significantly impair immune function

Off-Label Use for Healthy Adults Under 50

  • Not Routinely Recommended
    For healthy adults under 50 without immune issues, the CDC does not currently recommend routine vaccination before age 50.
  • Clinician Discretion
    In some cases, clinicians may consider “off-label” use of Shingrix for younger adults with unique risk factors not covered by standard guidelines.
  • Insurance Coverage
    Off-label use may not be covered by insurance for those under 50, so check your plan before scheduling.

Who Should Talk to a Doctor About Early Vaccination?

Consider discussing early shingles vaccination if you are under 50 and you:

  • Have a condition or treatment that weakens your immune system
  • Experience severe or recurrent stressors that affect immunity
  • Plan to start immunosuppressive therapy soon

Your healthcare provider can:

  • Review your medical history
  • Weigh benefits and risks in your specific case
  • Help navigate insurance or cost concerns

Vaccine Safety and Side Effects

Shingrix is a non-live, recombinant vaccine that has been studied extensively:

  • Common Side Effects
    • Soreness, redness or swelling at the injection site
    • Muscle pain, fatigue, headache, chills, fever
  • Duration
    • Side effects typically last 2–3 days
  • Serious Reactions
    • Rare; allergic reactions can occur and require immediate medical attention

Overall, Shingrix’s benefits in preventing shingles and its complications far outweigh the temporary discomfort of side effects for most people.


How to Prepare and What to Expect

  1. Schedule two doses, 2 to 6 months apart.
  2. Inform your provider about any allergies or past reactions to vaccines.
  3. Plan for possible mild side effects; take over-the-counter pain relief if needed.
  4. Keep your vaccination record for future reference.

Monitoring for Symptoms

If you have concerns about possible shingles symptoms—such as tingling, itching, or a blistering rash—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide if you need to seek prompt medical care.


Key Takeaways

  • Routine shingles vaccination is recommended at age 50 and older.
  • The FDA permits use of Shingrix in adults 18–49 with weakened immune systems.
  • Off-label vaccination for healthy adults under 50 is possible but not standard.
  • Discuss your personal risk factors and timing with your healthcare provider.
  • Side effects are usually mild and short-lived; serious reactions are rare.
  • For peace of mind about any symptoms, try the Ubie Symptom Checker.

When to Speak to a Doctor

Always speak to a doctor if you experience:

  • Severe, persistent, or worsening rash or pain
  • Signs of an allergic reaction (e.g., difficulty breathing, hives)
  • Any life-threatening or serious medical concerns

Your healthcare provider can offer personalized advice and ensure you get the right care at the right time.

(References)

  • * Hügle B, Suchowerskyj P, Schuster V. [Varicella vaccination: who should be vaccinated these days?]. MMW Fortschr Med. 2005 Feb 24;147(8):31-2, 34-5. PMID: 18441563.

  • * Wielawski IM. Shingles and the vaccine to prevent it. Am J Nurs. 2009 Jun;109(6):63-5. doi: 10.1097/01.NAJ.0000352478.78617.e2. PMID: 19478611; PMCID: PMC2939832.

  • * Gelb LD. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination. J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S18-21. PMID: 19553631.

  • * Stier DM, Weber IB, Staples JE. Lack of interference by zoster vaccine with the immune response to yellow fever vaccine. J Travel Med. 2012 Mar-Apr;19(2):122-3. doi: 10.1111/j.1708-8305.2011.00585.x. Epub 2012 Feb 28. PMID: 22414038; PMCID: PMC4669900.

  • * Taking a shot at shingles. Johns Hopkins Med Lett Health After 50. 2012 Aug;24(7):8. PMID: 23033561.

  • * Cogman AR, Chakravarty EF. The case for Zostavax vaccination in systemic lupus erythematosus. Vaccine. 2013 Aug 12;31(36):3640-3. doi: 10.1016/j.vaccine.2013.05.085. Epub 2013 Jun 3. PMID: 23742992; PMCID: PMC3952213.

  • * Oxman MN, Schmader KE. Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations. Clin Infect Dis. 2014 Oct;59(7):920-2. doi: 10.1093/cid/ciu501. Epub 2014 Aug 4. PMID: 25097080.

  • * Greenberg J. Ten Immunization-Related Tips in Outpatient Practice. Am J Med. 2017 Apr;130(4):417-419. doi: 10.1016/j.amjmed.2016.09.040. Epub 2016 Nov 4. PMID: 27818229.

  • * Xu F, deJong N, Kappelman MD, Greenlund KJ, Carlson SA. Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 May 2;29(5):726-734. doi: 10.1093/ibd/izac129. PMID: 35779060.

  • * Stempniewicz N, Davenport E, Wang J, Sweeney C. Herpes zoster vaccination: Primary care provider knowledge, attitudes, and practices. Hum Vaccin Immunother. 2025 Dec;21(1):2488093. doi: 10.1080/21645515.2025.2488093. Epub 2025 Apr 18. PMID: 40249278; PMCID: PMC12013443.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.